Measurement of HIV Risk to Create Demand for Safe Male Circumcision
Using the Rakai HIV Risk Index to Measure and Communicate HIV Risk to Create Demand for Safe Male Circumcision: A Randomized Controlled Trial
1 other identifier
interventional
968
1 country
1
Brief Summary
The study is aimed at testing whether use of a new index to measure risk for HIV in the context of HIV testing and counseling will increase demand for safe male circumcision (SMC) services among HIV-negative non-muslim men in Rakai. We will also study whether use of the index leads to positive sexual behavioral modifications among men. The study will also measure acceptability of the index among men.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hiv
Started Nov 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
April 7, 2016
CompletedFirst Posted
Study publicly available on registry
May 17, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedMay 17, 2016
April 1, 2016
1.6 years
April 7, 2016
May 12, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Circumcision status as reported on a questionnaire and confirmed by examination
Circumcision status of men ascertained using a questionnaire and confirmed by examination
6 months
Secondary Outcomes (1)
Condom use at last non-marital relationship as reported on a questionnaire
6 months
Study Arms (2)
Enhanced HIV counseling and testing
EXPERIMENTALIn addition to standard HIV testing and counseling,men randomized to this arm received Measurement and communication of HIV risk from the HIV counselors using an index developed and validated through the Rakai community cohort study. Their risk was communicated to them and subsequent HIV risk reduction counseling including male circumcision was given.
Standard HIV testing and counseling
ACTIVE COMPARATORMen randomized to this arm were given standard HIV testing and counseling following the current Uganda Ministry of Health guidelines. Following the counseling HIV risk reduction counseling including male circumcision was given.
Interventions
Measurement and communication of HIV risk in the context of HIV testing and counseling to inform HIV risk reduction counseling
Participants received HIV testing and counseling following standard Ministry of Health guidelines
Eligibility Criteria
You may qualify if:
- Uncircumcised, non-muslim, HIV-negative, sexually active in the previous 12 months
You may not qualify if:
- Refuses HIV testing, not willing to stay in Rakai for at least 6 months following enrollment or unwilling to be traced
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rakai Health Sciences Programlead
- Bill and Melinda Gates Foundationcollaborator
- Johns Hopkins Bloomberg School of Public Healthcollaborator
- Makerere Universitycollaborator
Study Sites (1)
Rakai Health Sciences Program
Kalisizo, Rakai, 256, Uganda
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph Kagaayi, Ph.D
Rakai Health Sciences Program
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 7, 2016
First Posted
May 17, 2016
Study Start
November 1, 2014
Primary Completion
June 1, 2016
Study Completion
June 1, 2016
Last Updated
May 17, 2016
Record last verified: 2016-04
Data Sharing
- IPD Sharing
- Will not share
Data will be published in peer-reviewed journals and at scientific conferences.